Africa's Iboga Root: A Treasure in Peril

Iboga root, a plant central to Gabonese ritual traditions, is attracting global attention for its potential in treating addiction and certain mental illnesses. This interest is driven by pharmaceutical companies exploring ibogaine, a compound derived from the root bark.

Traditionally used in Gabonese spiritual practices like Bwiti, iboga is cultivated and harvested with deep cultural significance. However, the increasing demand from abroad threatens the plant's ecological balance, as commercial extraction methods can lead to unsustainable harvesting practices and harm wild populations.

Early studies, including one involving US veterans, suggest ibogaine may significantly reduce symptoms of PTSD, depression, and anxiety. This has spurred political support, with the US directing federal agencies to explore treatment pathways for eligible patients and allocating substantial funds for clinical trials.

In response to these developments, Gabon has taken protective measures. A government decree in May 2026 recognized traditional knowledge associated with iboga as national heritage, mandating benefit-sharing for commercial use. This was followed by a September 2026 decree prohibiting the export of iboga and its derivatives, aiming to conserve both the plant and its associated cultural knowledge.

The international focus on ibogaine mirrors past cases of plant-based medicines becoming global industries, such as ayahuasca. Gabon aims to proactively set terms for commercial use while the market is still developing, emphasizing the importance of Indigenous voices in protecting their natural and cultural resources.